Emmac
European Medical Cannabis Company. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
$286m (Public information from Mar 2021)
Company register number 11253633
London England (HQ)
Financials
Estimates*
| GBP | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenues | - | 5.3m | 12.8m | 17.3m | 24.3m |
| % growth | - | - | 140 % | 36 % | 40 % |
| EBITDA | (<1m) | (10.0m) | (7.9m) | (26.8m) | (17.1m) |
| % EBITDA margin | - | (187 %) | (62 %) | (155 %) | (70 %) |
| Profit | (<1m) | (10.7m) | (9.4m) | (41.9m) | (30.9m) |
| % profit margin | - | (201 %) | (74 %) | (242 %) | (127 %) |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $5.3m | Early VC | |
N/A | Convertible | ||
* | $286m Valuation: $286m 17.0x EV/LTM Revenues -27.5x EV/LTM EBITDA | Acquisition | |
| Total Funding | $5.3m | ||
Related Content
Recent News about Emmac
EditMore about Emmac
EditCuraleaf Medical is the scientific arm of Curaleaf International. Our team focuses on advancing our understanding of the potential therapeutic value of cannabis used for medicinal purposes (also known as medical marajuana) and how we can develop products that meet the needs of people all across Europe.
Investments by Emmac
Edit
ACQUISITION by Emmac Jan 2019